Ultrasound versus Conventional Treat-To-Target Strategies in Early Rheumatoid Arthritis: Magnetic Resonance Imaging Outcome Data from a 2-year Randomized Controlled Strategy Trial

被引：0
|
作者：
Sundin, Ulf [1 ,2 ]
Aga, Anna-Birgitte [1 ]
Skare, Oivind [1 ]
Nordberg, Lena [1 ]
Uhlig, Till [3 ]
Hammer, Hilde [1 ]
van der Heijde, Desiree [4 ]
Kvien, Tore [3 ]
Lillegraven, Siri [1 ]
Haavardsholm, Espen [3 ]
机构：
[1] Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway
[2] Univ Oslo, Oslo, Norway
[3] Univ Oslo, Diakonhjemmet Hosp, Dept Rheumatol, Fac Med, Oslo, Norway
[4] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0280
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Long-term efficacy of a 2-year MRI treat-to-target strategy on disease activity and radiographic progression in patients with rheumatoid arthritis in clinical remission: 5-year follow-up of the IMAGINE-RA randomised trial
    Moller-Bisgaard, Signe
    Horslev-Petersen, Kim
    Ornbjerg, Lykke Midtboll
    Ejbjerg, Bo
    Hetland, Merete Lund
    Moller, Jakob Mollenbach
    Nielsen, Sabrina Mai
    Glinatsi, Daniel
    Boesen, Mikael
    Stengaard-Pedersen, Kristian
    Madsen, Ole Rintek
    Jensen, Bente
    Villadsen, Jan Alexander
    Hauge, Ellen Margrethe
    Hendricks, Oliver
    Lindegaard, Hanne
    Krogh, Niels Steen
    Jurik, Anne Grethe
    Thomsen, Henrik
    Christensen, Robin
    Ostergaard, Mikkel
    RMD OPEN, 2024, 10 (01):
  • [32] Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction: a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA)
    Horslev-Petersen, K.
    Hetland, M. L.
    Ornbjerg, L. M.
    Junker, P.
    Podenphant, J.
    Ellingsen, T.
    Ahlquist, P.
    Lindegaard, H.
    Linauskas, A.
    Schlemmer, A.
    Dam, M. Y.
    Hansen, I.
    Lottenburger, T.
    Ammitzboll, C. G.
    Jorgensen, A.
    Krintel, S. B.
    Raun, J.
    Johansen, J. S.
    Ostergaard, M.
    Stengaard-Pedersen, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (09) : 1645 - 1653
  • [33] AN MRI GUIDED TREAT-TO-TARGET STRATEGY IN RHEUMATOID ARTHRITIS PATIENTS IN CLINICAL REMISSION IMPROVED MRI INFLAMMATION BUT NOT DAMAGE PROGRESSION - RESULTS FROM THE IMAGINE-RA RANDOMISED CONTROLLED TRIAL
    Moller-Bisgaard, S.
    Horslev-Pedersen, K.
    Ejbjerg, B.
    Glinatsi, D.
    Hetland, M.
    Ornbjerg, L.
    Moller, J.
    Boesen, M.
    Christensen, R.
    Stengaard-Pedersen, K.
    Madsen, O. R.
    Jensen, B.
    Villadsen, J.
    Hauge, E. -M.
    Bennett, P.
    Hendricks, O.
    Asmussen, K.
    Kowalski, M.
    Lindegaard, H.
    Nielsen, S. M.
    Bliddal, H.
    Krogh, N.
    Ellingsen, T.
    Nielsen, A. H.
    Balding, L.
    Jurik, A. G.
    Thomsen, H.
    Ostergaard, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 126 - 126
  • [34] Magnetic Resonance Imaging-Targeted Versus Systematic Prostate Biopsies: 2-year Follow-up of a Prospective Randomized Trial (PRECISE)
    Klotz, Laurence
    Chin, Joseph
    Black, Peter C.
    Finelli, Antonio
    Anidjar, Maurice
    Machado, Ashley
    Levental, Mark
    Ghai, Sangeet
    Chang, Silvia D.
    Patel, Chirag
    Kassam, Zahra
    Loblaw, Andrew
    Kebabdjian, Marlene
    Pond, Greg
    Haider, Masoom A.
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (03): : 456 - 461
  • [35] Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial
    Eriksson, Jonas K.
    Karlsson, Johan A.
    Bratt, Johan
    Petersson, Ingemar F.
    van Vollenhoven, Ronald F.
    Ernestam, Sofia
    Geborek, Pierre
    Neovius, Martin
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) : 1094 - 1101
  • [36] AURANOFIN IMPROVES OUTCOME IN EARLY RHEUMATOID-ARTHRITIS - RESULTS FROM A 2-YEAR, DOUBLE-BLIND, PLACEBO CONTROLLED-STUDY
    BORG, G
    ALLANDER, E
    LUND, B
    BERG, E
    BRODIN, U
    PETTERSSON, H
    TRANG, L
    JOURNAL OF RHEUMATOLOGY, 1988, 15 (12) : 1747 - 1754
  • [37] A Treat-To-Target Strategy With Methotrexate and Intra-Articular Triamcinolone With Or Without Added Adalimumab Reduces Synovitis, Osteitis and Tenosynovitis and Halts Structural Damage Progression In Early Rheumatoid Arthritis: The Opera Magnetic Resonance Imaging Sub-Study
    Axelsen, Mette Bjorndal
    Eshed, Iris
    Horslev-Petersen, Kim
    Steengaard-Petersen, Kristian
    Hetland, Merete L.
    Moller, Jakob M.
    Junker, Peter
    Podenphant, Jan
    Ellingsen, Torkell
    Ahlquist, Palle
    Lindegaard, Hanne M.
    Linauskas, Asta
    Schlemmer, Annette
    Dam, Mette Yde
    Hansen, Ib
    Horn, Hans Chr
    Ammitzboll, Christian G.
    Jorgensen, Anette
    Krintel, Sophine B.
    Raun, Johnny
    Johansen, Julia S.
    Krogh, Niels Steen
    Ostergaard, Mikkel
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1199 - S1199
  • [38] Pain Over Two Years After Start of Biologic Versus Conventional Combination Treatment in Early Rheumatoid Arthritis: Results From a Swedish Randomized Controlled Trial
    Olofsson, Tor
    Wallman, Johan K.
    Joud, Anna
    Schelin, Maria E. C.
    Ernestam, Sofia
    van Vollenhoven, Ronald
    Saevarsdottir, Saedis
    Lampa, Jon
    ARTHRITIS CARE & RESEARCH, 2021, 73 (09) : 1312 - 1321
  • [39] Treat-to-target strategy for LDL-cholesterol improvement in type 2 diabetes: post-hoc analysis of data from the 2-year follow-up of the MIND.IT study
    Scheffer, P. G.
    Tushuizen, M. E.
    Vermue, R. F.
    Rustemeijer, C.
    Heine, R. I.
    Diamant, M.
    DIABETOLOGIA, 2008, 51 : S557 - S558
  • [40] LONG TERM EFFICACY OF A 2-YEAR MRI TREAT-TO-TARGET STRATEGY ON DISEASE ACTIVITY, MRI INFLAMMATION AND PHYSICAL FUNCTION IN RHEUMATOID ARTHRITIS PATIENTS IN CLINICAL REMISSION: FIVE YEAR FOLLOW-UP OF THE IMAGINE RA-COHORT
    Moller-Bisgaard, S.
    Horslev-Petersen, K.
    Glinatsi, D.
    Ejbjerg, B.
    Hetland, M. L.
    Moller, J. Mollenbach
    Christensen, R.
    Nielsen, S. M.
    Boesen, M.
    Stengaard-Pedersen, K.
    Madsen, O.
    Jensen, B.
    Villadsen, J. A.
    Hauge, E. M.
    Hendricks, O.
    Lindegaard, H. M.
    Krogh, N. Steen
    Jurik, A. G.
    Thomsen, H.
    Ostergaard, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 539 - 540
12345